There have been multiple accounts created with the sole purpose of posting advertisement posts or replies containing unsolicited advertising.

Accounts which solely post advertisements, or persistently post them may be terminated.

news

This magazine is from a federated server and may be incomplete. Browse more on the original instance.

Alex Murdaugh, already convicted of murder, will be sentenced for stealing from 18 clients (apnews.com)

For years, South Carolina attorney Alex Murdaugh looked his anguished clients in the eyes and promised to help them with their medical bills, their suffering or simply to survive. Then he stole some, if not all, of what he won for many of them....

A millennial startup founder who’s turning carbon emissions into rocks lays out how he’ll eliminate 1 million tons by 2030—and what a great mentor Bill Gates’ Breakthrough Energy has been (fortune.com)

Talal Hasan, founder and CEO of carbon elimination company 44.01, talks net-zero targets and what it’s like working with a Bill Gates venture.

Trump tells appeals court that threats to judge and clerk in NY civil fraud trial do not justify gag order (www.cnn.com)

Donald Trump urged a New York appeals court to continue to pause the gag order against him in his civil fraud trial, saying that threats to the judge and his law clerk do not “justify” limiting the former president’s constitutional right to defend himself....

Births have increased in states with abortion bans, research finds (www.cnn.com)

Nearly a quarter of people seeking an abortion in the United States were unable to get one due to bans that took effect after the Supreme Court’s Dobbs decision, researchers estimate. In the first half of 2023, states with abortion bans had an average fertility rate that was 2.3% higher than states where abortion was not...

FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors (www.fda.gov)

Today, the U.S. Food and Drug Administration approved Ogsiveo (nirogacestat) tablets for adult patients with progressing desmoid tumors who require systemic treatment. Ogsiveo is the first drug to be approved for the treatment of patients with desmoid tumors, a rare subtype of soft tissue sarcomas.

  • All
  • Subscribed
  • Moderated
  • Favorites
  • [email protected]
  • random
  • lifeLocal
  • goranko
  • All magazines